Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Enzo Biochem
ENZ

Buy Enzo Biochem (ENZ) Stock

ENZ
See ENZ stock price and Buy/Sell Enzo Biochem with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
ENZ

Enzo Biochem (ENZ)

About Enzo Biochem (ENZ)

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable customers to meet their clinical needs. It operates through the following segments: Products, Clinical Services, and Therapeutics. The Products segment develops, manufactu...Read more
Market Cap
$115.93M
1 Year High
$4.15
Volume
12.38k
1 Year Low
$2.23
Price to Earnings Ratio
440.74
Open
$2.36
Dividend Rate
High
$2.41
Dividend Yield
Low
$2.33

Community

People who own or watch ENZ stock

Enzo Biochem Stock News

Enzo Biochem stock rating

What analysts recommend for ENZ stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1

Enzo Biochem price target

What analysts think ENZ will be worth
Low $2.23
High $12
Current $2.41
Target $12

Events

List of events that could affect ENZ stock.
14Mar

Earnings data Q4 2021

09Jun

Earnings data Q1 2022

Enzo Biochem earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.06
-0.11
-0.17
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020

Expected EPS
Q4 2020
-$0.07
Actual EPS
Q4 2020

Buy Enzo Biochem (ENZ) Stock

ENZ
See ENZ stock price and Buy/Sell Enzo Biochem with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch ENZ stock
  • BrooklynRoy avatar
  • tumie avatar
  • Trejo73 avatar
  • ledesma1968 avatar
  • HabitZero avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.